Skba Capital Management LLC Amgen Inc Transaction History

Skba Capital Management LLC

$617 Million
Q1 2024

A detailed history of Skba Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Skba Capital Management LLC holds 21,406 shares of AMGN stock, worth $6.65 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares

21,406

Previous 21,661 1.18%

Holding current value

$6.65 Million

Previous $6.24 Million 2.44%

% of portfolio

0.99%

Previous 1.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $68,561 - $82,762	-255 Reduced 1.18%	21,406 $6.09 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $5.01 Million - $5.65 Million	-19,600 Reduced 47.5%	21,661 $6.24 Million
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $2.35 Million - $2.77 Million	10,950 Added 36.13%	41,261 $9.16 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $11,289 - $13,760	50 Added 0.17%	30,311 $7.33 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $2.44 Million - $3.1 Million	-10,650 Reduced 26.03%	30,261 $7.95 Million

Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $16,834 - $18,986	75 Added 0.18%	40,911 $9.22 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $992,053 - $1.1 Million	-4,300 Reduced 9.53%	40,836 $9.94 Million
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $40,345 - $44,632	-184 Reduced 0.41%	45,136 $10.9 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $2.89 Million - $3.31 Million	-14,550 Reduced 24.3%	45,320 $10.2 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $2.57 Million - $2.85 Million	-11,000 Reduced 15.52%	59,870 $14.6 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $998,595 - $1.16 Million	-4,500 Reduced 5.97%	70,870 $17.6 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $3.92 Million - $4.66 Million	18,100 Added 31.6%	75,370 $17.3 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $793,117 - $882,011	-3,380 Reduced 5.57%	57,270 $14.6 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $98,905 - $121,370	-500 Reduced 0.82%	60,650 $14.3 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $662,235 - $851,200	-3,500 Reduced 5.41%	61,150 $14.7 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $1.78 Million - $2.13 Million	10,200 Added 18.73%	64,650 $12.5 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $1.92 Million - $2.25 Million	-11,500 Reduced 17.44%	54,450 $10 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $1.14 Million - $1.28 Million	-6,300 Reduced 8.72%	65,950 $12.5 Million
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $936,600 - $1.09 Million	-5,250 Reduced 6.77%	72,250 $14.1 Million
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $3.87 Million - $4.37 Million	20,900 Added 36.93%	77,500 $16.1 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $91,327 - $102,580	-550 Reduced 0.96%	56,600 $10.4 Million
Q1 2018 May 08, 2018	BUY	$169.43 - $198.0 $33,886 - $39,600	200 Added 0.35%	57,150 $9.74 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $632,962 - $707,212	3,750 Added 7.05%	56,950 $9.9 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $8.9 Million - $10.2 Million	53,200	53,200 $9.92 Million

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skba Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Skba Capital Management LLC with notifications on news.

Account

Skba Capital Management LLC Amgen Inc Transaction History